Trial
NCT03291054
Epacadostat and Pembrolizumab in Patients With GIST
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
—
Condition
Gastrointestinal Stromal Tumors
Intervention
Pembrolizumab
Why stopped
Study ended prematurely at the request of the funding sponsor.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-11